Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028

Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028



The global neurovascular devices market is projected to reach USD 5.5 Billion by 2028 from USD 3.6 Billion in 2023, at a CAGR of 8.7% during the forecast period. The increase in the demand for neurovascular devices market is driven by the increasing population proportion at a risk of developing various neurovascular diseases such as Ischemic stroke, cerebral aneurysms owing to the growing prevalence of hypertension, diabetes, and obesity. However, high cost of neuro-interventional procedures and associated products and shortage of skilled neurologists across emerging countries are likely to hamper the growth of market.

“Ischemic stroke segment accounted for the highest CAGR during the forecast period”

Based on disease pathology, the neurovascular devices market is segmented into cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies (includes cavernous malformations and moyamoya disease). The ischemic stroke segment to grow a at a higher CAGR owing to increasing incidence of ischemic stroke and increase in the mechanical thrombectomy procedures.

“The Hospitals & surgical centers segment accounted for the largest market share in the neurovascular devices market, by end user, during the forecast period”

Based on end user, the neurovascular devices market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes. The hospital & surgical centers captured the largest share of neurovascular devices market during the forecast period attributed to the increasing hospitalization of target patient population, rising volume of neurovascular surgeries, and upgradation in the infrastructure of hospitals in developing nations along with the availability of technological advance neurovascular treatment devices in these settings.

“The North America segment accounted for the highest market share in the neurovascular devices market, by region, during the forecast period”

Based on the region, the global neurovascular devices market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to the factors such as strong adoption of endovascular treatment procedures for the ischemic stroke, cerebral aneurysm, and arteriovenous malformation, availability of R& D investments for development of novel neurovascular devices, strong foothold of key players in region, and favorable reimbursement policy for neurovascular treatment procedures.

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (30%), Tier 2 (45%), and Tier 3 (25%)

By Designation: C-level (20%), Director-level (20%), and Others (45%)

By Region: North America (40%), Asia- Pacific (30%), Europe (20%), Latin America (7%) and Middle East & Africa(3%)

Prominent companies include Stryker (US), Johnson & Johnson (US), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), Kaneka Corporation (Japan), BALT (France), Perflow Medical Ltd. (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co., Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd. (Japan), Imperative Care (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), Cerus Endovascular Inc. (USA), and Zylox-Tonbridge Medical Co., Ltd (China)

Research Coverage

This research report categorizes the neurovascular devices market by disease pathology (cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies), by end user (hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the neurovascular devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the neurovascular devices market. Competitive analysis of upcoming startups in the neurovascular devices market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall neurovascular devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (rising incidence of neurovascular diseases, increasing neurovascular procedures, availability of medical reimbursement, and expansion of healthcare infrastructure across emerging nations), restraints (high neurovascular procedural & related devices cost and shortage of skilled neurosurgeon in emerging countries ), opportunities (increase in the preference of minimally invasive neurosurgical procedures and rising R& D activities in neurovascular therapies), and challenges (stringent regulatory approval process for neurovascular treatment devices) influencing the growth of the neurovascular devices market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the neurovascular devices market.

Market Development: Comprehensive information about lucrative markets – the report analyses the neurovascular devices market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices market

Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Stryker (US), Johnson & Johnson (US), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), among others in the neurovascular devices market strategies.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS
    • STUDY SCOPE
      • MARKETS COVERED
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED
    • CURRENCY CONSIDERED
    • MARKET STAKEHOLDERS
    • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
      • PRODUCT-BASED MARKET ESTIMATION
      • VOLUME-BASED MARKET ESTIMATION
      • PRIMARY RESEARCH VALIDATION
    • DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS AND LIMITATIONS
      • RESEARCH ASSUMPTIONS
      • RESEARCH LIMITATIONS
    • RECESSION IMPACT
      • Table GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH)
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • NEUROVASCULAR DEVICES MARKET OVERVIEW
    • NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023 VS. 2028 (USD MILLION)
    • NEUROVASCULAR DEVICES MARKET, BY REGION AND DISEASE PATHOLOGY (2022)
    • NEUROVASCULAR DEVICES MARKET, BY COUNTRY
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • SUPPLY CHAIN ANALYSIS
    • VALUE CHAIN ANALYSIS
    • PORTER'S FIVE FORCES ANALYSIS
      • OVERVIEW
        • Table NEUROVASCULAR DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
        • Table US FDA: MEDICAL DEVICE CLASSIFICATION
        • Table US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • EUROPE
      • ASIA PACIFIC
    • REIMBURSEMENT SCENARIO
      • Table REIMBURSEMENT CODES FOR VARIOUS PROCEDURES (2021)
    • PRICING TREND ANALYSIS
      • AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY KEY PLAYER, 2021 (USD)
      • AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY REGION/COUNTRY, 2021 (USD)
    • PATENT ANALYSIS
    • TRADE ANALYSIS
      • Table IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017-2021 (USD MILLION)
      • Table EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016-2020 (USD MILLION)
    • ECOSYSTEM MAP
    • CASE STUDY ANALYSIS
      • STENT-ASSISTED COILING (SAC) THERAPY FOR INTRACRANIAL ANEURYSMS
        • Table USAGE OF INTRACRANIAL STENTS FOR TREATMENT OF BROAD-NECKED INTRACRANIAL ANEURYSMS
    • KEY CONFERENCES AND EVENTS IN 2022-2023
      • Table NEUROVASCULAR DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    • STAKEHOLDERS AND BUYING CRITERIA
      • KEY STAKEHOLDERS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATION SEGMENTS (%)
    • KEY BUYING CRITERIA
      • Table KEY BUYING CRITERIA FOR NEUROVASCULAR DEVICES
  • NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY
    • INTRODUCTION
      • Table NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • CEREBRAL ANEURYSMS
      • Table NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY END USER, 2021-2028 (USD MILLION)
      • EMBOLIC COILS
        • Table CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY REGION, 2021-2028 (USD MILLION)
        • Table CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CEREBRAL ANEURYSMS MARKET FOR BARE DETACHABLE COILS, BY REGION, 2021-2028 (USD MILLION)
        • Table CEREBRAL ANEURYSMS MARKET FOR COATED DETACHABLE COILS, BY REGION, 2021-2028 (USD MILLION)
      • FLOW DIVERSION DEVICES
        • Table CEREBRAL ANEURYSMS MARKET FOR FLOW DIVERSION DEVICES, BY REGION, 2021-2028 (USD MILLION)
      • INTRACRANIAL STENTS
        • Table CEREBRAL ANEURYSMS MARKET FOR INTRACRANIAL STENTS, BY REGION, 2021-2028 (USD MILLION)
      • MICROCATHETERS
        • Table CEREBRAL ANEURYSMS MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION)
      • GUIDEWIRES
        • Table CEREBRAL ANEURYSMS MARKET FOR GUIDEWIRES, BY REGION, 2021-2028 (USD MILLION)
    • ISCHEMIC STROKES
      • Table NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY TYPE 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY END USER, 2021-2028 (USD MILLION
      • CLOT RETRIEVER DEVICES
        • Table ISCHEMIC STROKES MARKET FOR CLOT RETRIEVER DEVICES, BY REGION, 2021-2028 (USD MILLION)
      • SUCTION & ASPIRATION DEVICES
        • Table ISCHEMIC STROKES MARKET FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2021-2028 (USD MILLION)
      • VASCULAR SNARES
        • Table ISCHEMIC STROKES MARKET FOR VASCULAR SNARES, BY REGION, 2021-2028 (USD MILLION)
      • MICROCATHETERS
        • Table ISCHEMIC STROKES MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION)
      • MICROGUIDEWIRES
        • Table ISCHEMIC STROKES MARKET FOR MICROGUIDEWIRES, BY REGION, 2021-2028 (USD MILLION)
      • BALLOON CATHETERS
        • Table ISCHEMIC STROKES MARKET FOR BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION)
    • CAROTID ARTERY STENOSIS
      • Table NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS CAROTID ARTERY STENOSIS, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY END USER, 2021-2028 (USD MILLION)
      • CAROTID ARTERY STENTS
        • Table CAROTID ARTERY STENOSIS MARKET FOR CAROTID ARTERY STENTS, BY REGION, 2021-2028 (USD MILLION)
      • EMBOLIC PROTECTION DEVICES
        • Table CAROTID ARTERY STENOSIS MARKET FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2021-2028 (USD MILLION)
      • BALLOON CATHETERS
        • Table CAROTID ARTERY STENOSIS MARKET FOR BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION)
    • ARTERIOVENOUS MALFORMATION & FISTULAS
      • Table NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY END USER, 2021-2028 (USD MILLION)
      • LIQUID EMBOLIC AGENTS
        • Table ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021-2028 (USD MILLION)
      • OCCLUSION BALLOON CATHETERS
        • Table ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR OCCLUSION BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION)
      • MICROCATHETERS
        • Table ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER DISEASE PATHOLOGIES
      • Table NEUROVASCULAR DEVICES MARKET FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2021-2028 (USD MILLION)
      • Table NEUROVASCULAR DEVICES MARKET FOR OTHER DISEASE PATHOLOGIES, BY END USER, 2021-2028 (USD MILLION)
  • NEUROVASCULAR DEVICES MARKET, BY END USER
    • INTRODUCTION
      • Table NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • HOSPITALS AND SURGICAL CENTERS
      • INCREASING VOLUME OF NEUROVASCULAR PROCEDURES DUE TO AVAILABILITY OF ADVANCED EQUIPMENT TO DRIVE MARKET
        • Table NEUROVASCULAR DEVICES MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • AMBULATORY CARE CENTERS
      • OPERATIONAL AND ECONOMIC BENEFITS OFFERED BY ACCS TO DRIVE MARKET
        • Table NEUROVASCULAR DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
      • INCREASING COLLABORATIONS FOR DEVELOPMENT OF TECHNOLOGICALLY ADVANCED NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH
        • Table NEUROVASCULAR DEVICES MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • NEUROVASCULAR DEVICES MARKET, BY REGION
    • INTRODUCTION
      • Table NEUROVASCULAR DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • NORTH AMERICA: RECESSION IMPACT
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • US
        • Table US: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table US: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: EMBOLIC COILS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table CANADA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: EMBOLIC COILS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
    • EUROPE
      • EUROPE: RECESSION IMPACT
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table GERMANY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table FRANCE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • UK
        • Table UK: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table UK: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table ITALY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table SPAIN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • ASIA PACIFIC: RECESSION IMPACT
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table JAPAN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table CHINA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table INDIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
    • LATIN AMERICA
      • LATIN AMERICA: RECESSION IMPACT
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • MEXICO
        • Table MEXICO: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table MEXICO: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • SHORTAGE OF NEUROSURGEONS AND POOR HEALTHCARE COVERAGE TO RESTRAIN MARKET GROWTH
      • MIDDLE EAST & AFRICA: RECESSION IMPACT
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021- 2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
      • STRATEGIES ADOPTED BY KEY PLAYERS
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
    • COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2022)
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SME EVALUATION QUADRANT (2022)
      • PROGRESSIVE COMPANIES
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
    • NEUROVASCULAR DEVICES MARKET: FOOTPRINT ANALYSIS OF LEADING PLAYERS
      • Table COMPANY FOOTPRINT ANALYSIS
      • Table PRODUCT FOOTPRINT
      • Table REGIONAL FOOTPRINT
      • PRODUCT LAUNCHES & APPROVALS
        • Table NEUROVASCULAR DEVICES MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2019-MARCH 2023)
      • DEALS
        • Table NEUROVASCULAR DEVICES MARKET: KEY DEALS (JANUARY 2019-MARCH 2023)
      • OTHER DEVELOPMENTS
        • Table NEUROVASCULAR DEVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2019-MARCH 2023)
  • COMPANY PROFILES
    • KEY PLAYERS
      • STRYKER
        • Table STRYKER: BUSINESS OVERVIEW
      • MEDTRONIC
        • Table MEDTRONIC: BUSINESS OVERVIEW
      • JOHNSON & JOHNSON
        • Table JOHNSON & JOHNSON: BUSINESS OVERVIEW
      • TERUMO CORPORATION
        • Table TERUMO CORPORATION: BUSINESS OVERVIEW
      • PENUMBRA, INC.
        • Table PENUMBRA, INC.: BUSINESS OVERVIEW
      • MICROPORT SCIENTIFIC CORPORATION
        • Table MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
      • BALT
        • Table BALT: BUSINESS OVERVIEW
      • KANEKA CORPORATION
        • Table KANEKA CORPORATION: BUSINESS OVERVIEW
        • Table PRODUCT LAUNCHES
      • PHENOX GMBH
        • Table PHENOX GMBH: BUSINESS OVERVIEW
      • ASAHI INTECC CO., LTD
        • Table ASAHI INTECC CO., LTD.: BUSINESS OVERVIEW
      • PERFLOW MEDICAL LTD.
        • Table PERFLOW MEDICAL LTD.: BUSINESS OVERVIEW
      • RAPID MEDICAL
        • Table RAPID MEDICAL: BUSINESS OVERVIEW
      • CERUS ENDOVASCULAR INC.
        • Table CERUS ENDOVASCULAR INC.: BUSINESS OVERVIEW
      • ACANDIS GMBH
        • Table ACANDIS GMBH: BUSINESS OVERVIEW
        • Table ACANDIS GMBH: PRODUCTS OFFERED
      • EVASC
        • Table EVASC: BUSINESS OVERVIEW
      • SENSOME
        • Table SENSOME: BUSINESS OVERVIEW
      • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
        • Table LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: BUSINESS OVERVIEW
      • IMPERATIVE CARE
        • Table IMPERATIVE CARE: BUSINESS OVERVIEW
        • Table IMPERATIVE CARE: PRODUCT LAUNCHES AND APPROVALS
      • MEDIKIT CO., LTD.
        • Table MEDIKIT CO., LTD.: BUSINESS OVERVIEW
      • ZYLOX-TONBRIDGE MEDICAL CO., LTD.
        • Table ZYLOX-TONBRIDGE MEDICAL CO., LTD.: BUSINESS OVERVIEW
        • Table ZYLOX-TONBRIDGE MEDICAL CO., LTD.: PRODUCT LAUNCHES AND APPROVALS
    • OTHER PLAYERS
      • SILK ROAD MEDICAL, INC.
      • ARTIO MEDICAL, INC.
      • IVASCULAR
      • OXFORDENDOVASCULAR
      • NEUROVASC TECHNOLOGIES, INC.
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings